A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU

Clinical trial NCT05913336 · COMPLETED

Trial details

NCT number: NCT05913336
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sedation in the ICU

Start date: 2023-06-27
Primary completion: 2025-03-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.